|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||0.1900 - 0.1961|
|52-week range||0.1900 - 4.6000|
|Beta (5Y monthly)||2.95|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
BURLINGTON, Ontario, November 14, 2023--Anaergia Inc. (TSX: ANRG) announces its financial results for the three- and nine-month periods ended September 30, 2023, and its related MD&A.
BURLINGTON, Ontario, November 13, 2023--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) will release financial results for the third quarter of 2023 prior to market open on Tuesday, November 14, 2023.
BURLINGTON, Ontario, September 28, 2023--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) today announced that its subsidiary Rhode Island Bioenergy Facility, LLC ("RIBF") has closed a US$20 million term loan ("Loan") with East West Bank, a California Corporation, to finance remaining construction and commissioning of the RIBF project in the Town of Johnston, Rhode Island, USA and working capital. This financing has a seven-year term, and bears interest on US dollar denominated drawn fund